comprehensive -WSS

comprehensive

author：leisure time 2025-09-27 09:40:06 - browse：15752

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Why medical students are struggling with mental health

WSS

U.K. considers world's first use of meningitis vaccine to address gonorrhea

CRISPR pioneers react to Casgevy, first gene

Pig kidney works a record two months in donated body

Telehealth for opioid use disorder is lifesaving

Walmart eyes Medicare Advantage provider ChenMed

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

hotspot

comprehensive

entertainment

Affirmative action in medical school literally saved lives

Diverse clinical trials: Why aren’t we there yet?

How to save PrEP access — and even expand it

PEPFAR is under serious threat — and so is global health

Virginia high school admissions case could be legal follow

Congress must reauthorize a committee to support older Americans

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Walmart eyes Medicare Advantage provider ChenMed

explore

White House touts steps to stem shortages of cancer treatments

How housing is health care on Long Island

Acelyrin, a rare IPO success, stumbles in its first big test

Why medical students are struggling with mental health

CRISPR pioneers react to Casgevy, first gene

Wegovy, Zepbound and weight loss drugs that preserve muscle

entertainment

focus

entertainment

hotspot